Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 92

1.

Diabetes Mellitus and Age are Risk Factors of Interval Colon Cancer: A Case-Control Study.

Laish I, Mizrahi J, Naftali T, Konikoff FM.

Dig Dis. 2019;37(4):291-296. doi: 10.1159/000496740. Epub 2019 Feb 7.

PMID:
30731459
2.

Risk of metachronous advanced lesions after resection of diminutive and small, non-advanced adenomas.

Laish I, Sergeev I, Stein A, Naftali T, Konikoff FM.

Clin Res Hepatol Gastroenterol. 2019 Apr;43(2):201-207. doi: 10.1016/j.clinre.2018.03.001. Epub 2018 Sep 25.

PMID:
30266580
3.

Identification of Synergistic Interaction Between Cannabis-Derived Compounds for Cytotoxic Activity in Colorectal Cancer Cell Lines and Colon Polyps That Induces Apoptosis-Related Cell Death and Distinct Gene Expression.

Nallathambi R, Mazuz M, Namdar D, Shik M, Namintzer D, Vinayaka AC, Ion A, Faigenboim A, Nasser A, Laish I, Konikoff FM, Koltai H.

Cannabis Cannabinoid Res. 2018 Jun 1;3(1):120-135. doi: 10.1089/can.2018.0010. eCollection 2018.

4.

Telomere Length, Aggregates, and Capture in Cirrhosis.

Laish I, Mari A, Mannasse B, Hadary R, Konikoff FM, Amiel A, Kitay-Cohen Y.

Isr Med Assoc J. 2018 May;5(20):295-299.

5.

Surveillance after positive colonoscopy based on adenoma characteristics.

Laish I, Seregeev I, Naftali T, Konikoff FM.

Dig Liver Dis. 2017 Oct;49(10):1115-1120. doi: 10.1016/j.dld.2017.05.005. Epub 2017 May 16.

PMID:
28641945
6.

Cannabis in Inflammatory Bowel Diseases: from Anecdotal Use to Medicalization?

Naftali T, Konikoff FM.

Isr Med Assoc J. 2017 Feb;19(2):95-97. No abstract available.

7.

Low-Dose Cannabidiol Is Safe but Not Effective in the Treatment for Crohn's Disease, a Randomized Controlled Trial.

Naftali T, Mechulam R, Marii A, Gabay G, Stein A, Bronshtain M, Laish I, Benjaminov F, Konikoff FM.

Dig Dis Sci. 2017 Jun;62(6):1615-1620. doi: 10.1007/s10620-017-4540-z. Epub 2017 Mar 27.

PMID:
28349233
8.

Soluble Syndecan-1: A Novel Biomarker of Small Bowel Mucosal Damage in Children with Celiac Disease.

Yablecovitch D, Oren A, Ben-Horin S, Fudim E, Eliakim R, Saker T, Konikoff FM, Kopylov U, Matthias T, Lerner A.

Dig Dis Sci. 2017 Mar;62(3):755-760. doi: 10.1007/s10620-016-4415-8. Epub 2016 Dec 26.

PMID:
28025744
9.

Telomere Dysfunction in Nonalcoholic Fatty Liver Disease and Cryptogenic Cirrhosis.

Laish I, Mannasse-Green B, Hadary R, Biron-Shental T, Konikoff FM, Amiel A, Kitay-Cohen Y.

Cytogenet Genome Res. 2016;150(2):93-99. doi: 10.1159/000454654. Epub 2016 Dec 23.

PMID:
28006764
10.

Low prevalence of dysplastic polyps in patients with ulcerative colitis.

Laish I, Shurani A, Barkay O, Konikoff FM, Naftali T.

Clin Res Hepatol Gastroenterol. 2017 Mar;41(2):204-209. doi: 10.1016/j.clinre.2016.09.009. Epub 2016 Nov 9.

PMID:
27838112
11.

Aneuploidy and asynchronous replication in non-alcholic fatty liver disease and cryptogenic cirrhosis.

Laish I, Mannasse-Green B, Hadary R, Konikoff FM, Amiel A, Kitay-Cohen Y.

Gene. 2016 Nov 15;593(1):162-166. doi: 10.1016/j.gene.2016.08.017. Epub 2016 Aug 9.

PMID:
27520584
12.

Reply.

Naftali T, Reshef L, Kovacs A, Porat R, Amir I, Konikoff FM, Gophna U.

Inflamm Bowel Dis. 2016 May;22(5):E15-6. doi: 10.1097/MIB.0000000000000782. No abstract available.

PMID:
27096566
13.

Distinct Microbiotas are Associated with Ileum-Restricted and Colon-Involving Crohn's Disease.

Naftali T, Reshef L, Kovacs A, Porat R, Amir I, Konikoff FM, Gophna U.

Inflamm Bowel Dis. 2016 Feb;22(2):293-302. doi: 10.1097/MIB.0000000000000662.

PMID:
26752462
14.

[BILE DUCT PROBLEMS - ENDOSCOPIC SOLUTIONS].

Benjaminov F, Barkay O, Konikoff FM.

Harefuah. 2015 Aug;154(8):525-9, 539. Review. Hebrew.

PMID:
26480620
15.

Interactions between the intestinal microbiota and bile acids in gallstones patients.

Keren N, Konikoff FM, Paitan Y, Gabay G, Reshef L, Naftali T, Gophna U.

Environ Microbiol Rep. 2015 Dec;7(6):874-80. doi: 10.1111/1758-2229.12319. Epub 2015 Aug 7.

PMID:
26149537
16.

Yield of second surveillance colonoscopy to predict adenomas with high-risk characteristics.

Laish I, Blechman I, Feingelernt H, Konikoff FM.

Dig Liver Dis. 2015 Sep;47(9):805-10. doi: 10.1016/j.dld.2015.05.005. Epub 2015 May 19.

PMID:
26048253
17.

Telomere dysfunction in peripheral blood lymphocytes from patients with primary sclerosing cholangitis and inflammatory bowel disease.

Laish I, Katz H, Stein A, Liberman M, Naftali T, Kitay-Cohen Y, Biron-Shental T, Konikoff FM, Amiel A.

Dig Liver Dis. 2015 Sep;47(9):790-6. doi: 10.1016/j.dld.2015.05.002. Epub 2015 May 13.

PMID:
26048252
18.

Pouch Inflammation Is Associated With a Decrease in Specific Bacterial Taxa.

Reshef L, Kovacs A, Ofer A, Yahav L, Maharshak N, Keren N, Konikoff FM, Tulchinsky H, Gophna U, Dotan I.

Gastroenterology. 2015 Sep;149(3):718-27. doi: 10.1053/j.gastro.2015.05.041. Epub 2015 May 27.

PMID:
26026389
19.

Asynchronous Replication in Lymphocytes from Patients with Inflammatory Bowel Disease and Primary Sclerosing Cholangitis.

Laish I, Biron-Shental T, Katz H, Liberman M, Kitay-Cohen Y, Konikoff FM, Amiel A.

Cytogenet Genome Res. 2015;145(1):35-41. doi: 10.1159/000381406. Epub 2015 Apr 11.

PMID:
25895441
20.

Soluble Syndecan-1 Levels Are Elevated in Patients with Inflammatory Bowel Disease.

Yablecovitch D, Stein A, Shabat-Simon M, Naftali T, Gabay G, Laish I, Oren A, Konikoff FM.

Dig Dis Sci. 2015 Aug;60(8):2419-26. doi: 10.1007/s10620-015-3589-9. Epub 2015 Feb 22.

PMID:
25702042

Supplemental Content

Loading ...
Support Center